傲农生物(603363) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,783,121,593.70, a decrease of 25.95% compared to CNY 2,407,845,116.90 in the same period last year[4] - Net profit attributable to shareholders was CNY 218,305,329.33, a significant recovery from a loss of CNY 292,019,915.86 in the previous year[4] - Basic and diluted earnings per share were both CNY 0.08, compared to a loss of CNY -0.34 per share in the previous year[5] - Operating profit for Q1 2025 was CNY 226,825,281.34, compared to a loss of CNY 375,395,437.68 in Q1 2024[20] - Net profit for Q1 2025 was CNY 221,671,023.85, recovering from a net loss of CNY 372,743,346.37 in Q1 2024[21] - The company reported a significant investment income of CNY 250,414,865.92 in Q1 2025, compared to a loss of CNY 2,766,470.08 in Q1 2024[20] Cash Flow - The net cash flow from operating activities was negative at CNY -345,853,887.69, worsening from CNY -28,696,382.95 in the same period last year[4] - Total cash inflow from operating activities was 1,691,355,405.04, compared to 2,325,261,513.89 previously[24] - Cash outflow from operating activities totaled 2,037,209,292.73, down from 2,353,957,896.84[24] - The net cash flow from investing activities was -92,430,532.43, a significant decline from 60,620,390.18 in the prior period[24] - The net cash flow from financing activities was -156,877,037.09, worsening from -39,797,304.02 in the previous period[24] - The ending cash and cash equivalents balance was 536,523,685.07, down from 1,131,687,533.40 at the beginning of the period[24] Assets and Liabilities - Total assets decreased by 3.29% to CNY 9,193,538,073.43 from CNY 9,506,097,034.21 at the end of the previous year[5] - The company's current assets decreased to RMB 3,268,062,678.55 from RMB 3,699,211,726.04, reflecting a decline of about 11.63%[15] - The company's total liabilities decreased to CNY 5,769,579,246.89 in Q1 2025 from CNY 6,444,948,812.96 in Q1 2024[17] - Total liabilities decreased to RMB 5,705,240,309.62 from RMB 6,178,313,232.07, indicating a decline of approximately 7.65%[16] - The company reported a total equity of RMB 3,488,297,763.81 as of March 31, 2025, down from RMB 3,327,783,802.14, reflecting an increase of about 4.83%[16] - Total equity increased to CNY 3,423,958,826.54 in Q1 2025 from CNY 3,061,148,221.25 in Q1 2024[17] Operational Insights - The decline in operating revenue was mainly due to reduced feed sales and a decrease in the number of pigs sold[7] - The company plans to focus on improving operational efficiency and exploring new market opportunities in the upcoming quarters[7] - The company has a total of 540,000 pigs, including 109,200 breeding sows as of the end of the reporting period[12] Inventory and Borrowings - The company's inventory increased to RMB 834,543,287.70 from RMB 816,935,693.48, showing a growth of approximately 2.07%[15] - The company's short-term borrowings decreased to RMB 555,693,967.33 from RMB 765,327,341.90, a reduction of about 27.39%[16] - The company’s long-term borrowings increased to RMB 1,512,720,086.14 from RMB 1,462,234,553.47, an increase of approximately 3.93%[16] Accounting Standards - The company will not apply new accounting standards starting from 2025[25]